Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines
This article describes the pharmacology of approved parenteral anticoagulants. These
include the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight …
include the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight …
Biochemistry and genetics of von Willebrand factor
JE Sadler - Annual review of biochemistry, 1998 - annualreviews.org
Von Willebrand factor (VWF) is a blood glycoprotein that is required for normal hemostasis,
and deficiency of VWF, or von Willebrand disease (VWD), is the most common inherited …
and deficiency of VWF, or von Willebrand disease (VWD), is the most common inherited …
Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
Abbreviations: ACT activated clotting time; APTT activated partial thromboplastin time; AT
antithrombin; AT-III antithrombin III; CI confidence interval; DVT deep vein thrombosis; GP …
antithrombin; AT-III antithrombin III; CI confidence interval; DVT deep vein thrombosis; GP …
Low-molecular-weight heparins
JI Weitz - New England Journal of Medicine, 1997 - Mass Medical Soc
After almost two decades of intensive research, low-molecular-weight heparins have
established their niche as an important class of antithrombotic compounds. The …
established their niche as an important class of antithrombotic compounds. The …
Adhesion mechanisms in platelet function
ZM Ruggeri, GL Mendolicchio - Circulation research, 2007 - Am Heart Assoc
Platelet adhesion is an essential function in response to vascular injury and is generally
viewed as the first step during which single platelets bind through specific membrane …
viewed as the first step during which single platelets bind through specific membrane …
Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Hirsh, R Raschke - Chest, 2004 - Elsevier
This article about unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH)
is part of the Seventh American College of Chest Physicians Conference on Antithrombotic …
is part of the Seventh American College of Chest Physicians Conference on Antithrombotic …
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists …
VA Ferraris, SP Ferraris, SP Saha, EA Hessel II… - The Annals of thoracic …, 2007 - Elsevier
BACKGROUND: A minority of patients having cardiac procedures (15% to 20%) consume
more than 80% of the blood products transfused at operation. Blood must be viewed as a …
more than 80% of the blood products transfused at operation. Blood must be viewed as a …
Guide to anticoagulant therapy: Heparin: a statement for healthcare professionals from the American Heart Association
Thrombi are composed of fibrin and blood cells and may form in any part of the
cardiovascular system, including veins, arteries, the heart, and the microcirculation. Because …
cardiovascular system, including veins, arteries, the heart, and the microcirculation. Because …
Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines
This chapter describes the pharmacology of approved parenteral anticoagulants, including
the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight heparins …
the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight heparins …
von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes
AO Spiel, JC Gilbert, B Jilma - Circulation, 2008 - Am Heart Assoc
von Willebrand factor (VWF) plays a pivotal role in platelet adhesion and aggregation at
sites of high shear rates (eg, in coronary arteries that have stenotic or ruptured …
sites of high shear rates (eg, in coronary arteries that have stenotic or ruptured …